Clinical Roundup

Clinical Roundup

EXALT-1 trial shows benefit of AI-supported functional precision medicine platform in late-stage hematological cancer

Researchers from Exscientia, the Medical University of Vienna, and the CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences demonstrated the impact of using Exscientia’s AI-supported precision medicine platform to propose which therapy would be most effective for late-stage hematological cancer patients, based on testing drug responses ex vivo in their own tissue samples.
Clinical RoundupFree

Chronic stress may impact treatment completion, survival outcomes in patients with breast cancer

Researchers at The Ohio State University Comprehensive Cancer Center—Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC-James) showed that chronic physiologic “wear and tear” from stress, known as allostatic load, may be associated with a decreased likelihood of cancer treatment completion and lower overall survival.